A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of ...
Civica announced today that it plans to launch an affordable long-acting insulin in pre-filled pens starting in January 2026.
On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration for its insulin pump system is near.
MannKind (Nasdaq:MNKD) announced today that the FDA accepted a supplemental biologics license for its Afrezza inhaled insulin ...
Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback